The report offers detailed coverage of Colchicine industry and main market trends.
Colchicine is an alkaloid extracted from the bulb of colchicum. This medicine is used to treat acute attacks of gouty arthritis and prevent acute exacerbation of recurrent gouty arthritis.
Colchicine is a highly effective drug for the treatment of acute gout, but 50% to 80% of patients taking colchicine have had gastrointestinal side effects before the onset of gout, which has affected the growth of the colchicine market.
Colchicine has been FDA approved for use in combination with probenicid for gout since 1982. As part of a program to promote safety studies for grandfathered meds, in 2009 the FDA approved its use for acute gout flares, gout prophylaxis, and Familial Mediterranean Fever. It is also used off-label for pseudogout, Behcet\'s disease, pericarditis, and primary biliary cirrhosis.
The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Colchicine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Colchicine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2026.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
First, this report covers the present status and the future prospects of the global Colchicine market for 2015-2026.
In this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Takeda Pharmaceuticals
Hikma
Cipla
Wockhardt
West-Ward
Excellium Pharmaceutical
Rhea Pharmaceutical
Medinova
Odan Laboratories
Prasco
Kunming Pharmaceutical
Yunnan Plant Medicine
Xishuangbanna Pharmaceutical
Guangdong Pedi
Yunnan Shan State
Tonghua Limin
Beijing Jialin Pharmaceutical
At the same time, we classify Colchicine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market by Order Type
Tablet
Oral Solution
Market by Application
Acute Gout
Chronic Gout
Other Conditions
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Colchicine market for the forecast period 2021 - 2026?
• What are the driving forces in the Colchicine market for the forecast period 2021 - 2026?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Colchicine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.